Surveys

TIF SURVEY | Sickle Cell Disease Patients’ Views on Oxbryta

OXBRYTA (voxelotor) is a prescription medicine used for the treatment of sickle cell disease (SCD) and constitutes the first aproved treatment that directly inhibits sickle hemoglobin polymerization, the root cause…

Leggi di più »